UMass Amherst team makes cancer ‘research breakthrough’
An exterior view of the Institute for Applied Life Sciences at University of Massachusetts Amherst is shown Oct. 21, 2016. GAZETTE FILE PHOTO
Published: 5/7/2021 5:35:06 PM
AMHERST Researchers at the University of Massachusetts Amherst have discovered a mechanism for more effectively delivering medical treatment to specific cells, representing a possible breakthrough in cancer treatment.
The research team at the university’s Center for Bioactive Delivery, based in the Institute for Applied Life Sciences, has managed to engineer a nanoparticle they say could revolutionize the way cancer-fighting drugs are delivered to specific cells. In a study published in the peer-reviewed journal of the German Chemical Society, Angewandte Chemie, the scientists explained that the nanoparticle combines two different approaches to delivering treatment to cells.
Team of UMass Amherst researchers unveils the latest advance in targeted delivery of therapeutic proteins
May 6, 2021
The advantage of PACs over other therapies. Courtesy: S. Thai Thayumanavan
AMHERST, Mass. – A team of researchers at the Center for Bioactive Delivery at the University of Massachusetts Amherst’s Institute for Applied Life Sciences has engineered a nanoparticle that has the potential to revolutionize disease treatment, including for cancer. This new research, which appears today in “
Angewandte Chemie,”combines two different approaches to more precisely and effectively deliver treatment to the specific cells affected by cancer.
Two of the most promising new treatments involve delivery of cancer-fighting drugs via biologics or antibody-drug conjugates (ADCs). Each has its own advantages and limitations. Biologics, such as protein-based drugs, can directly substitute for a malfunctioning protein in cells. As a result, they have less serious side e
UMass team identifies cancer research breakthrough
Updated May 06, 2021;
Posted May 06, 2021
The University of Massachusetts Amherst Institute for Applied Life Sciences has been a home for research into the treatment of cancer and other diseases, where scientists say they are making a breakthrough. (JIM KINNEY/ THE REPUBLICAN)
Facebook Share
A team of University of Massachusetts Amherst researchers has announced the engineering of a tiny particle it says has the potential to revolutionize disease treatment, including for cancer.
The new research combines two different approaches to more precisely and effectively deliver treatment to the specific cells affected by cancer. The work has been ongoing at the UMass Amherst Institute for Applied Life Sciences, where researchers say a nanoparticle has far-reaching potential.